Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN114182272B reveals a metal-free electrocatalytic method for synthesizing alcohol and pinacol derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114182272B reveals a metal-free electrochemical route for alcohol and pinacol derivatives, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Novel zinc powder reduction method for 2,3,5-trichloropyridine. High yield, eco-friendly solvent system, optimized for commercial scale-up and cost efficiency.
Patent CN101519384A details a one-step synthesis of chiral oxazolines. Offers high enantioselectivity for asymmetric catalysis and scalable manufacturing solutions.
Patent CN116554056A reveals a novel one-pot base-catalyzed synthesis for high-purity cyclohexane intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN106380466B details a high-purity cobalt-catalyzed route. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Patent CN101319236A details a green biocatalytic method for chiral alcohols using ionic liquids. Achieve high purity and cost reduction in pharma intermediate manufacturing with scalable processes.
Patent CN116554056A reveals a novel one-pot base-catalyzed route for cyclohexane derivatives, offering significant cost reduction in fine chemical manufacturing and high-purity outcomes.
Patent CN113429349B details a novel Cu/g-C3N4 catalyzed route for 2-trifluoromethyl benzimidazoles, offering mild conditions and recyclable catalysts for cost-effective manufacturing.
Novel biocatalytic route for chiral alcohol intermediates ensures >99% ee and scalable production for beta-3 agonists.
Patent CN101602713B reveals a novel alkaline hydrolysis route for 2-chloronicotinic acid, offering 93% yield and significant cost reduction in agrochemical intermediate manufacturing.
Patent CN106748605A details a green TBAB-Oxone method for o-dicarbonyl compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN116356354A reveals a green electrochemical route for 2-aryl-3-sulfonyl compounds, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN101823941A details a catalyst-free, water-based chlorination process for PCMX, offering significant cost reduction and environmental compliance for disinfectant manufacturing.
Patent CN111116441B details a recyclable sulfur ylide method for epoxide synthesis, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN114574880A details a metal-free electrochemical method for fluoroalkyl hydrazones. This green synthesis offers significant cost reduction and scalability for pharmaceutical manufacturing.
Novel 3-step route for Salan ligands via CN102786466A. High yield, mild conditions, scalable process for asymmetric catalysis applications.
Patent CN108164398A details a novel reduction method eliminating column chromatography. This breakthrough ensures scalable production and substantial cost reduction for global supply chains.
Novel patent CN104211644B enables high-yield production. Offers supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Novel axial and central chirality catalyst enables high enantioselectivity. Reduces costs in pharmaceutical intermediates manufacturing with scalable synthesis.